Esperion Therapeutics ESPR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's operating lease ROU assets?
- Esperion Therapeutics (ESPR) reported operating lease ROU assets of $2.7M in Q1 2026.
- How has Esperion Therapeutics's operating lease ROU assets changed year-over-year?
- Esperion Therapeutics's operating lease ROU assets decreased by 45.6% year-over-year, from $4.97M to $2.7M.
- What is the long-term trend for Esperion Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Esperion Therapeutics's operating lease ROU assets has grown at a -13.5% compound annual growth rate (CAGR), from $6.03M to $2.92M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.